Less Is More?
Open Access
- 9 April 2025
- journal article
- case report
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (11) , 103315
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-upJAMA Cardiology, 2019
- Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trialEuroIntervention, 2019
- Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold ImplantationJACC, 2017
- Bioresorbable Scaffolds versus Metallic Stents in Routine PCINew England Journal of Medicine, 2017
- First Observation of a “Golden Tube” After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft VasculopathyJACC: Cardiovascular Interventions, 2017
- Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trialThe Lancet, 2016
- Bioresorbable Vascular Scaffolds for Coronary RevascularizationCirculation, 2016
- Bioresorbable Coronary Scaffold ThrombosisJACC, 2016
- Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery DiseaseNew England Journal of Medicine, 2015
- Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in HumansCirculation, 2014